BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2009147)

  • 1. Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril.
    Ogihara T; Kaneko Y; Ikeda M; Yamada K; Omae T; Arakawa K; Ishii M; Yoshinaga K; Kumahara Y; Kokubu T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):42S-45S. PubMed ID: 2009147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood pressure and metabolic response to converting enzyme inhibitor in hypertensive patients: comparison between delapril and captopril].
    Chu TS; Wu MS; Chen YM; Wu KD
    J Formos Med Assoc; 1992 Dec; 91 Suppl 4():S288-92. PubMed ID: 1363526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of delapril in hypertensive patients along the cardiovascular continuum.
    González-Juanatey JR; Cordero A
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):271-81. PubMed ID: 23469905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of a new angiotensin converting enzyme inhibitor: delapril.
    Saruta T; Nishikawa K
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):23S-28S. PubMed ID: 2009144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practitioner's Trial on the Efficacy of Antihypertensive Treatment in the Elderly Hypertension (The PATE-Hypertension Study) in Japan.
    Ogihara T
    Am J Hypertens; 2000 May; 13(5 Pt 1):461-7. PubMed ID: 10826395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antihypertensive effects of delapril and enalapril.
    Rahn KH
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):38S-41S. PubMed ID: 2009146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the effects of delapril, a new angiotensin converting enzyme inhibitor, on the diurnal variation of arterial pressure in patients with essential hypertension using indirect and direct arterial pressure monitoring methods.
    Miyakawa T; Minamisawa K; Yamada Y; Sasaki O; Fujiki Y; Tochikubo O; Ishii M
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):29S-37S. PubMed ID: 2009145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delapril/manidipine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(7):961-9. PubMed ID: 16740017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function.
    Minamisawa K; Shionoiri H; Sugimoto K; Ueda S; Ashino K; Ebina T; Gotoh E; Ishii M
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1417-23. PubMed ID: 2177631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Razzetti R; Acerbi D
    Am J Cardiol; 1995 Jun; 75(18):7F-12F. PubMed ID: 7778536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dry cough in the elderly patients treated with angiotensin converting enzyme inhibitor].
    Kaku T; Yamasaki H; Harada N; Tsujino M; Inoue G
    Nihon Ronen Igakkai Zasshi; 1991 May; 28(3):365-70. PubMed ID: 1895531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive treatment: a combination of delapril, a new ACE-inhibitor, and indapamide].
    Coruzzi P; Ravanetti C; Alberici M; Novarini A
    Clin Ter; 1990 Jan; 132(1):45-9. PubMed ID: 2139371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat.
    Mizuno K; Tani M; Niimura S; Yamaguchi M; Inagami T; Fukuchi S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):60S-66S. PubMed ID: 2009151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delapril plus indapamide: a review of the combination in the treatment of hypertension.
    Cavalieri L; Cremonesi G
    Clin Drug Investig; 2007; 27(6):367-80. PubMed ID: 17506588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congestive heart failure in elderly patients: controlled study of delapril versus captopril.
    Acanfora D; Lanzillo T; Papa A; Longobardi G; Furgi G; Rengo C; Melillo E; Rengo F
    Am J Cardiol; 1995 Jun; 75(18):37F-43F. PubMed ID: 7778533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety and efficacy of delapril with captopril in outpatients with congestive heart failure.
    Fuchs W
    Am J Cardiol; 1995 Jun; 75(18):29F-36F. PubMed ID: 7778531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, randomized, placebo-controlled, double-blind study of the safety and efficacy of oral delapril in patients with congestive heart failure.
    Circo A; Platania F; Mangiameli S; Putignano E
    Am J Cardiol; 1995 Jun; 75(18):18F-24F. PubMed ID: 7778529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D
    Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.